Related references
Note: Only part of the references are listed.MiRNA-21-5p Accelerates EMT and Inhibits Apoptosis of Laryngeal Carcinoma via Inhibiting KLF6 Expression
Yanjun Xu
BIOCHEMICAL GENETICS (2023)
Circular RNA circPOFUT1 enhances malignant phenotypes and autophagy-associated chemoresistance via sequestrating miR-488-3p to activate the PLAG1-ATG12 axis in gastric cancer
Ming Luo et al.
CELL DEATH & DISEASE (2023)
Extracellular Vesicle-Loaded Oncogenic lncRNA NEAT1 from Adipose-Derived Mesenchymal Stem Cells Confers Gemcitabine Resistance in Pancreatic Cancer via miR-491-5p/Snail/SOCS3 Axis
Rongxiang Wu et al.
STEM CELLS INTERNATIONAL (2023)
Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study
Amy Makler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis
Chonghui Hu et al.
MOLECULAR CANCER (2022)
Hsa_circ_0074298 promotes pancreatic cancer progression and resistance to gemcitabine by sponging miR-519 to target SMOC
Chen Hong et al.
JOURNAL OF CANCER (2022)
Circular RNA circ-MTHFD1L induces HR repair to promote gemcitabine resistance via the miR-615-3p/RPN6 axis in pancreatic ductal adenocarcinoma
Zhi-Wen Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer
Ke-Da Yang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2022)
Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
Jianyou Gu et al.
MOLECULAR CANCER (2022)
Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair
Xiang Zhang et al.
ONCOGENE (2022)
Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis
Xin Ye et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
microRNA-497 prevents pancreatic cancer stem cell gemcitabine resistance, migration, and invasion by directly targeting nuclear factor kappa B 1
Qiangfeng Yu et al.
Aging-US (2022)
Glycolysis-Related LINC02432/Hsa-miR-98-5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma
Peng Tan et al.
FRONTIERS IN PHARMACOLOGY (2022)
Pancreatic ductal adenocarcinoma cells regulated the gemcitabine-resistance function of CAFs by LINC00460
Xiao-Xu Zhu et al.
CANCER SCIENCE (2022)
Long non-coding RNA SNHG16 decreased SMAD4 to induce gemcitabine resistance in pancreatic cancer via EZH2-mediated epigenetic modification
Yi Yu et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2022)
CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1
Yeting Lu et al.
JOURNAL OF ONCOLOGY (2022)
DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling
Hui Huang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2022)
N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway
Chengjie Lin et al.
BIOLOGY DIRECT (2022)
LINC00671 suppresses cell proliferation and metastasis in pancreatic cancer by inhibiting AKT and ERK signaling pathway
Shibin Qu et al.
CANCER GENE THERAPY (2021)
LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway
Fengyu Xu et al.
CANCER RESEARCH (2021)
MicroRNA-7 modulates cellular senescence to relieve gemcitabine resistance by targeting PARP1/NF-κB signaling in pancreatic cancer cells
Zhi-Qiang Ye et al.
ONCOLOGY LETTERS (2021)
Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance
Chuanxia Liu et al.
NEOPLASIA (2021)
Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer
Yoshihiko Tasaki et al.
CANCER RESEARCH (2021)
PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic Cancer
Yun-Fei Liu et al.
PANCREAS (2021)
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage
Pietro Carotenuto et al.
NATURE COMMUNICATIONS (2021)
MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism
An Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis
Shuo Yu et al.
GENES (2021)
Exosomal lncRNA UCA1 Derived From Pancreatic Stellate Cells Promotes Gemcitabine Resistance in Pancreatic Cancer via the SOCS3/EZH2 Axis
Yuan Chi et al.
FRONTIERS IN ONCOLOGY (2021)
MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer
Liu Ouyang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels
Concetta Panebianco et al.
BIOMOLECULES (2021)
Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 Regulation
Fei Xu et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy
Lei Wang et al.
Aging-US (2021)
Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis
Zhu Zeng et al.
ONCOGENE (2021)
Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating the miR-1227/E-Cadherin Pathway
Huiting Xu et al.
FRONTIERS IN ONCOLOGY (2021)
LncRNA SNHG7 Regulates Mesenchymal Stem Cell Through the Notch1/Jagged1/Hes-1 Signaling Pathway and Influences Folfirinox Resistance in Pancreatic Cancer
Dongfeng Cheng et al.
FRONTIERS IN ONCOLOGY (2021)
DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163/TOP2A and activating Wnt/β-catenin pathway
Shi-lei Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Long Noncoding RNA p53-Stabilizing and Activating RNA Promotes p53 Signaling by Inhibiting Heterogeneous Nuclear Ribonucleoprotein K deSUMOylation and Suppresses Hepatocellular Carcinoma
Geng Qin et al.
HEPATOLOGY (2020)
A Noncoding Regulatory RNAs Network Driven by Circ-CDYL Acts Specifically in the Early Stages Hepatocellular Carcinoma
Yanping Wei et al.
HEPATOLOGY (2020)
MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer
Jun Okazaki et al.
DIGESTION (2020)
Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma
Shulin Yu et al.
GUT (2020)
High Expression Levels of Long Noncoding RNA Small Nucleolar RNA Host Gene 18 and Semaphorin 5A Indicate Poor Prognosis in Multiple Myeloma
Ling-Juan Huang et al.
ACTA HAEMATOLOGICA (2020)
Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer
Wei Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study
Suneel D. Kamath et al.
ONCOLOGIST (2020)
Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210
Zhiyong Yang et al.
CELLULAR ONCOLOGY (2020)
Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma
Laura L. Meijer et al.
ANNALS OF SURGERY (2020)
LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis
Qiang Su et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Long non-coding RNA MEG3 regulates CSE-induced apoptosis and inflammation via regulating miR-218 in 16HBE cells
Beibei Song et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Comprehensive analysis of the regulatory network of differentially expressed mRNAs, lncRNAs and circRNAs in gastric cancer
Yingyi Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
EGFR-mediated autophagy in tumourigenesis and therapeutic resistance
Min Wu et al.
CANCER LETTERS (2020)
LncRNA XLOC_006390 promotes pancreatic carcinogenesis and glutamate metabolism by stabilizing c-Myc
Jun He et al.
CANCER LETTERS (2020)
The Long Noncoding RNA HOST2 Promotes Gemcitabine Resistance in Human Pancreatic Cancer Cells
Ning An et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
CircACAP2 promotes breast cancer proliferation and metastasis by targeting miR-29a/b-3p-COL5A1 axis
Beiyong Zhao et al.
LIFE SCIENCES (2020)
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Haiyang Zhang et al.
MOLECULAR CANCER (2020)
PIWIL-2 and piRNAs are regularly expressed in epithelia of the skin and their expression is related to differentiation
Johannes Pammer et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2020)
CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942
Chi Hin Wong et al.
CANCER RESEARCH (2020)
Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma
Shixiang Guo et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TROP -Mediated Degradation of NRF2 in Pancreatic Cancer
Qingzhu Yang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
miR-1231 Is Downregulated in Prostate Cancer with Prognostic and Functional Implications
Yitao Wang et al.
ONCOLOGY RESEARCH AND TREATMENT (2020)
Inhibiting microRNA-144 potentiates Nrf2-dependent antioxidant signaling in RPE and protects against oxidative stress-induced outer retinal degeneration
Ravirajsinh N. Jadeja et al.
REDOX BIOLOGY (2020)
CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1
Yunfei Liu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
LncRNA HOTTIP Participates in Cisplatin Resistance of Tumor Cells by Regulating miR-137 Expression in Pancreatic Cancer
Feng Yin et al.
ONCOTARGETS AND THERAPY (2020)
Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer
Ming-jie Jiang et al.
MOLECULAR CANCER (2020)
MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer
Zhi-qiang Ye et al.
DISEASE MARKERS (2020)
A Novel and Robust Long Noncoding RNA Panel to Predict the Prognosis of Pancreatic Cancer
Mengying Li et al.
DNA AND CELL BIOLOGY (2020)
Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis
Mengwei Wu et al.
LIFE SCIENCES (2020)
LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes
Cefan Zhou et al.
MOLECULAR CANCER (2020)
LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5p
Hanzhang Zhu et al.
PANCREATOLOGY (2020)
Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target
Joseph W. Franses et al.
NATURE COMMUNICATIONS (2020)
MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and Glycolysis
Mei-Juan Tu et al.
MOLECULAR PHARMACOLOGY (2020)
The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential
Gouri Pandya et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer
Lily Nguyen et al.
CANCERS (2020)
A Novel Autophagy-Related IncRNAs Signature for Prognostic Prediction and Clinical Value in Patients With Pancreatic Cancer
Zhengdong Deng et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Noncoding RNAs in drug-resistant pancreatic cancer: A review
Zhengjun Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
MiR-331-3p Links to Drug Resistance of Pancreatic Cancer Cells by Activating WNT/β-Catenin Signal via ST7L
Ting Zhan et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
LNC00673 suppresses proliferation and metastasis of pancreatic cancer via target miR-504/HNF1A
Yi Gong et al.
JOURNAL OF CANCER (2020)
MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG
Ning An et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
Leptin-elicited miRNA-342-3p potentiates gemcitabine resistance in pancreatic ductal adenocarcinoma
Longyang Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer
Xiufeng Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin
Wei Chen et al.
BIOMATERIALS (2019)
MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy
Huimin Lu et al.
BIOSCIENCE REPORTS (2019)
MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5
Zhi-Chao Wang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression
Weidong Shi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Cell cycle plasticity driven by MTOR signaling: integral resistance to CDK4/6 inhibition in patient-derived models of pancreatic cancer
Erik S. Knudsen et al.
ONCOGENE (2019)
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
Thorvardur R. Halfdanarson et al.
ONCOLOGIST (2019)
Chemotherapy for pancreatic cancer
Christoph Springfeld et al.
PRESSE MEDICALE (2019)
MiR-30a regulates cancer cell response to chemotherapy through SNAI1/IRS1/AKT pathway
Tingting Wang et al.
CELL DEATH & DISEASE (2019)
Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer
Yuan Fang et al.
EXPERIMENTAL CELL RESEARCH (2019)
Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer
Guangbing Xiong et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The biogenesis, biology and characterization of circular RNAs
Lasse S. Kristensen et al.
NATURE REVIEWS GENETICS (2019)
Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1
Yong-Qiang Hua et al.
AGING-US (2019)
MiR-760 enhances sensitivity of pancreatic cancer cells to gemcitabine through modulating Integrin β1
Dejun Yang et al.
BIOSCIENCE REPORTS (2019)
Coix Seed Extract Enhances the Anti-Pancreatic Cancer Efficacy of Gemcitabine through Regulating ABCB1-and ABCG2-Mediated Drug Efflux: A Bioluminescent Pharmacokinetic and Pharmacodynamic Study
Yifan Qian et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma
Yan Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF
Yunfei Liu et al.
ONCOTARGETS AND THERAPY (2019)
Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294
Yi Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
MicroRNA-200b and-301 are associated with gemcitabine response as biomarkers in pancreatic carcinoma cells
Naotake Funamizu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b
Liguo Hao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Targeting EphA2 with miR-124 mediates Erlotinib resistance in K-RAS mutated pancreatic cancer
Jing Du et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
Pancreatic Cancer Gene Therapy Delivered by Nanoparticles
Trevin Kurtanich et al.
SLAS TECHNOLOGY (2019)
Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5
Xing Qin et al.
GENOME BIOLOGY (2019)
Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma
Liangjing Zhou et al.
JOURNAL OF CANCER (2019)
The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors
Jose Eduardo Nunez et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
Glen J. Weiss et al.
INVESTIGATIONAL NEW DRUGS (2018)
MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells
Wenjie Hu et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Long non-coding RNA GAS5 antagonizes the chemoresistance of pancreatic cancer cells through down-regulation of miR-181c-5p
Zhi-Qiang Gao et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn
Guodong Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ductal adenocarcinoma
Libin Wang et al.
CANCER BIOMARKERS (2018)
miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA
Qing-An Zhang et al.
CANCER BIOMARKERS (2018)
MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy
Limin Huang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
miR-301a plays a pivotal role in hypoxia-induced gemcitabine resistance in pancreatic cancer
Guangtao Luo et al.
EXPERIMENTAL CELL RESEARCH (2018)
Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins
Di Sun et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
Guangbing Xiong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
LncRNA TUG1 promoted viability and associated with gemcitabine resistant in pancreatic ductal adenocarcinoma
Fan Yang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
Long non-coding RNA MEG3 functions as a tumour suppressor and has prognostic predictive value in human pancreatic cancer
Ling Ma et al.
ONCOLOGY REPORTS (2018)
Microarray analysis of circular RNA expression profiles associated with gemcitabine resistance in pancreatic cancer cells
Chao Xu et al.
ONCOLOGY REPORTS (2018)
Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer
Lulin Zhang et al.
ONCOLOGY RESEARCH (2018)
Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis
Qing-Guo Liu et al.
PANCREATOLOGY (2018)
The MiR-135b-BMAL1-YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistance
Weiliang Jiang et al.
CELL DEATH & DISEASE (2018)
Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
Feng Shao et al.
FRONTIERS IN PHARMACOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy
Tao Ma et al.
CANCER LETTERS (2018)
The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
Kazuya Kuwada et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer
Bingyan Liu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group
Antonio Irigoyen et al.
EUROPEAN JOURNAL OF CANCER (2017)
Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
Maria C. Previdi et al.
FUTURE ONCOLOGY (2017)
The long non-coding RNA HOTAIR enhances pancreatic cancer resistance to TNF-related apoptosis-inducing ligand
Shan-zhong Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Sequential Everolimus and Sunitinib Treatment in Pancreatic Metastatic Well-Differentiated Neuroendocrine Tumours Resistant to Prior Treatments
Anna Angelousi et al.
NEUROENDOCRINOLOGY (2017)
miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis
Rui-Meng Yang et al.
CELL DEATH & DISEASE (2017)
Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells
Yuran Gao et al.
CELL DEATH & DISEASE (2017)
MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy
Junjie Xiong et al.
ONCOTARGET (2017)
MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
Manabu Mikamori et al.
SCIENTIFIC REPORTS (2017)
miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer
Hidekazu Hiramoto et al.
SCIENTIFIC REPORTS (2017)
MicroRNA-1285 inhibits malignant biological behaviors of human pancreatic cancer cells by negative regulation of YAP1
H. Huang et al.
NEOPLASMA (2017)
MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells
Azam Rajabpour et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205
Amit Kumar Chaudhary et al.
CANCER LETTERS (2017)
miR-153 enhances the therapeutic effect of gemcitabine by targeting Snail in pancreatic cancer
Feng Liu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2017)
miR-142-5p regulates tumor cell PD-Ll expression and enhances anti-tumor immunity
Long Jia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
microRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancer
Prince Saforo Amponsah et al.
CANCER LETTERS (2017)
micorRNA-101 silences DNA-PKcs and sensitizes pancreatic cancer cells to gemcitabine
Hao Hu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
Girijesh Kumar Patel et al.
BRITISH JOURNAL OF CANCER (2017)
Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer
Shrey Modi et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2016)
MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer cells through targeting A20
Jie Yao et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2016)
Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells
R. Schreiber et al.
CANCER GENE THERAPY (2016)
MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer
Pei Fan et al.
CANCER LETTERS (2016)
Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling
J. Li et al.
ONCOGENE (2016)
MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1
Lijun Zhao et al.
TUMOR BIOLOGY (2016)
Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer
Xuefei Tian et al.
ONCOLOGY LETTERS (2016)
MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells
Yong Lin et al.
ONCOTARGET (2016)
MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulating PTEN and PDCD4
Xueju Wei et al.
CANCER MEDICINE (2016)
MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells
Weibin Wang et al.
SCIENTIFIC REPORTS (2016)
Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer
Mahito Miyamae et al.
BRITISH JOURNAL OF CANCER (2015)
Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc
Y. Liu et al.
GENE THERAPY (2015)
The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells
Michele Cioffi et al.
GUT (2015)
Long Noncoding RNA MALAT-1 Enhances Stem Cell-Like Phenotypes in Pancreatic Cancer Cells
Feng Jiao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer
Zhihua Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Upregulation of microRNA-138-5p inhibits pancreatic cancer cell migration and increases chemotherapy sensitivity
Chao Yu et al.
MOLECULAR MEDICINE REPORTS (2015)
Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer
Yue Zhao et al.
TARGETED ONCOLOGY (2015)
Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells
Yehua Shen et al.
TUMOR BIOLOGY (2015)
miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells
Chen Liang et al.
TUMOR BIOLOGY (2015)
MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine
Chen Liang et al.
ONCOTARGET (2015)
Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway
Meiyuan Chen et al.
ONCOTARGET (2015)
MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
Sameer A. Dhayat et al.
PLOS ONE (2015)
MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer
S. Hasegawa et al.
BRITISH JOURNAL OF CANCER (2014)
The TGFβ-miR200-MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR Inhibitors
Evgeny Izumchenko et al.
CANCER RESEARCH (2014)
MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX
Shin Hamada et al.
CELLULAR SIGNALLING (2014)
MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer
Marta Passadouro et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Autophagy-a key player in cellular and body metabolism
Kook Hwan Kim et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
MIR-211 MODULATES GEMCITABINE ACTIVITY THROUGH DOWNREGULATION OF RIBONUCLEOTIDE REDUCTASE AND INHIBITS THE INVASIVE BEHAVIOR OF PANCREATIC CANCER CELLS
Mina Maftouh et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2014)
MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3
Zhipeng Li et al.
TUMOR BIOLOGY (2014)
MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis
Jianwei Xu et al.
ONCOTARGET (2014)
miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1
Y. Iwagami et al.
BRITISH JOURNAL OF CANCER (2013)
MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells
Hiroaki Nagano et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL
Peng Wang et al.
MOLECULAR ONCOLOGY (2013)
miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2
Baobao Cai et al.
ONCOLOGY REPORTS (2013)
Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells
Daisuke Takiuchi et al.
PANCREATOLOGY (2013)
Differential Processing of let-7a Precursors Influences RRM2 Expression and Chemosensitivity in Pancreatic Cancer: Role of LIN-28 and SET Oncoprotein
Yangzom Doma Bhutia et al.
PLOS ONE (2013)
The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression
J. M. Houthuijzen et al.
BRITISH JOURNAL OF CANCER (2012)
miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells
Hai-jiao Yan et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Epigenetic Regulation by Long Noncoding RNAs
Jeannie T. Lee
SCIENCE (2012)
MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer
Kenoki Ohuchida et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Bcl-2 Upregulation Induced by miR-21 Via a Direct Interaction Is Associated with Apoptosis and Chemoresistance in MIA PaCa-2 Pancreatic Cancer Cells
Jie Dong et al.
ARCHIVES OF MEDICAL RESEARCH (2011)
Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells
Lei You et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Knockdown of microRNA-21 Inhibits Proliferation and Increases Cell Death by Targeting Programmed Cell Death 4 (PDCD4) in Pancreatic Ductal Adenocarcinoma
Imran Bhatti et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
Elisa Giovannetti et al.
CANCER RESEARCH (2010)
Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
Jin-Hyeok Hwang et al.
PLOS ONE (2010)
Pancreatic Cancer-Could It Be that Simple? A Different Context of Vulnerability
Daniel D. Von Hoff et al.
CANCER CELL (2009)
Antisense Inhibition of microRNA-21 or-221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma
Jong-Kook Park et al.
PANCREAS (2009)
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Qing Ji et al.
PLOS ONE (2009)
Share Paper
